Loading...
Chemical structure of JNJ4796

GC65968

JNJ4796

Also known as N-[2-[2-[4-[(R)-(2-methyltetrazol-5-yl)-phenylmethyl]piperazine-1-carbonyl]-4-pyridinyl]-1,3-benzoxazol-5-yl]acetamide

JNJ4796 is an oral active fusion inhibitor of influenza virus, neutralizing influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion· JNJ4796 mimics the functionality of the broadly neutralizing antibodies (bnAbs)

ChemicalCAS2241664-16-2MW537.57FormulaC28H27N9O3
CAS number
2241664-16-2
Molecular weight
537.57
Formula
C28H27N9O3
Solubility
DMSO ： 100 mg/mL (186·02 mM; Need ultrasonic)
InChIKey
VMAAUIZLAZYALS-RUZDIDTESA-N
Catalogue number
GC65968
Brand
GLPBIO
Computed properties PubChem CID 135302421 · XLogP 2.6 · TPSA 135 Ų · H-bond donors 1
XLogP
2.6
TPSA
135 Ų
H-bond donors
1
H-bond acceptors
9
Rotatable bonds
6
Heavy atoms
40

SMILES CC(=O)NC1=CC2=C(C=C1)OC(=N2)C3=CC(=NC=C3)C(=O)N4CCN(CC4)[C@H](C5=CC=CC=C5)C6=NN(N=N6)C

Computed descriptors from PubChem (CID 135302421), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.